January 8, 2013 – DrugRisk has learned that litigation against Bayer is growing over claims that their Mirena IUDs cause severe injury and side effects, as well as the need for removal surgery.
January 4, 2013 - Health regulators in France this week announced that they will no longer furnish certain birth control pills as part of national healthcare due to concerns over the increased risk of blood clots.
January 3, 2013 - Following conflicting advisories from the U.S. FDA over the safety of Pradaxa, the top drug safety agency in Australia has added new concern that the risks of the popular blood thinner may outweigh its benefits.
December 31, 2012 – A federal court in Missouri tasked with handling the growing number of injury claims involving the birth control device NuvaRing has reported that there are now approximately 1,000 cases pending from patients.
December 20, 2012 – Despite estimates that Bayer has settled more than 3,500 lawsuits alleging blood clots from their Yaz and Yasmin birth controls, patients continue to come forward who are seeking to learn about their legal options.
December 17, 2012 - The federal authority responsible for transferring nationwide mass tort litigation to centralized federal courts for resolution has reported that more than 1,025 women or families have now filed a NuvaRing lawsuit after suffering blood clot injuries allegedly tied to the birth control devices.
December 11, 2012 – German drug company Bayer announced this month that it will proceed with marketing of its new Jaydess contraceptive device in Europe after winning approval from the EMA.
December 7, 2012 - For decades, drug companies have been held to standards set by the Food and Drug Administration when promoting their products, allowing that they only market medications for approved purposes.
December 6, 2012 – German drug maker Bayer informed investors in its latest financial report that it has resolved as many as 3,500 Yaz lawsuits so far for a total cost of nearly $750 million. The average amount paid per case is around $214,000.
December 4, 2012 – Despite disagreement among experts on whether the blood thinner Pradaxa is more dangerous than traditional anticoagulants such as warfarin, litigation surrounding those injured or killed continues to grow.